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Abstract   
Cardiovascular disease (CVD) is the leading cause of mortality in the United States 
accounting for 1 out of every 3 deaths. Additionally, 43.9% of the population is expected 
to have some form of cardiovascular disease by the year 2030, with direct and indirect 
costs expected to rise upwards of 58 percent. To successfully prevent cardiovascular 
disease conditions such as myocardial infarction, coronary heart disease, and stroke, 
research must be done to identify risk factors, both modifiable and non-modifiable. In the 
existing literature, sleep duration as a risk factor for cardiovascular disease conditions has 
shown inconsistent associations. According to the National Sleep Foundation, the average 
adult needs between 7 and 9 hours of sleep per day, yet 50-70 million adults in the U.S. 
have some form of chronic sleep disorder. Furthermore, both short and long sleep 
duration is associated with known cardiovascular disease risk factors such as diabetes, 
hypertension, obesity, high cholesterol, depression, and overall metabolic dysfunction. 
This study aimed to determine if an association exists between deficient, and/or excessive 
sleep duration and myocardial infarction, coronary heart disease, and stroke, in the state 
of Nevada. The 2013 Behavioral Risk Factor Surveillance System (BRFSS) for the state 
of Nevada was assessed utilizing multiple logistic regression analysis in order to quantify 
risk. Results from the multiple logistic regression identified a total of twelve predictors of 
cardiovascular conditions in the final model. It was also determined that both deficient 
and excessive sleep duration was significantly associated with  myocardial infarction, 
coronary heart disease or angina, and stroke, throughout the study, even after adjustment 
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for covariates. The findings from this study can be used as additional evidence to 
encourage further research on improving sleep by developing future treatment therapies, 
and recommendations, that may help lower the risk of cardiovascular disease conditions.  
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Introduction 
 Cardiovascular disease, also termed heart disease or heart and blood vessel 
disease, is caused by an increase of plaque in the arteries. Plaque accumulation is termed 
atherosclerosis, a condition in which plaque builds up and narrows the arteries over time 
causing blood flow to be restricted. This restricted blood flow can lead to high blood 
pressure and blood clots, eventually causing angina, coronary heart disease, myocardial 
infarction, and/or strokes (American Heart Association, 2014). Angina, also known as 
chest pain, occurs when the area of the heart muscle doesn’t get enough oxygen-rich 
blood due to lack of blood flow. Angina can feel similarly to pressure or squeezing inside 
the chest and is usually a symptom of coronary heart disease. Coronary heart disease 
(CHD) arises when plaque accumulates specifically inside the coronary arteries, and 
denies oxygen-rich blood to the heart (National Heart, Lung, and Blood Institute, 2011). 
Since coronary heart disease is chronic in nature, it progresses into atherosclerosis over 
time. 
 Myocardial infarction, or MI, is a technical term for ‘heart attack’ that occurs 
when blood supply to the myocardium i.e. heart muscle, is stopped (Bolooki & Askari, 
2014). The causes for its cessation may be lack of blood flow, obstruction by a clot, or a 
plaque causes an artery to rupture. The end result of a diminished blood supply to the 
heart is cell death causing irreversible damage.  Lastly, stroke or ‘brain attack’, occurs 
when the flow of oxygen rich blood is blocked causing brain cell death. During an 
ischemic stroke, an artery to the brain becomes blocked or obstructed by clots, whereas 
during a hemorrhagic stroke, an artery within the brain ruptures or leaks blood (National 
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Heart, Lung, and Blood Institute, 2014).   Both types of strokes frequently cause paralysis 
of the face, arms, or legs, as well as vision loss, and difficulty with speech. 
Understanding cardiovascular disease and the various conditions it causes is essential for 
prevention of such debilitating, irreversible, life-long symptoms. 
Background 
Cardiovascular disease (CVD) is the leading cause of mortality in the United 
States accounting for 1 out of every 3 deaths (Go et al., 2014). Cardiovascular disease 
encompasses many vascular conditions such as myocardial infarction, coronary heart 
disease or angina, and stroke. Approximately 84 million American adults have 1 or more 
cardiovascular disease conditions with an estimated 42.2 million of these individuals 
aged 60 years or older (Go et al., 2014).  Prevalence estimates for cardiovascular disease 
conditions in 2010 include: myocardial infarction with 7.6 million (2.9%) affected 
individuals, coronary heart disease with 15.4 million (6.4%) affected individuals, and 
stroke with 6.8 million (2.8%) affected individuals (Go et al., 2014). New, and recurrent 
stroke prevalence is estimated at 795,000 individuals with mortality at 129,476 
individuals for 2010 (Go et al., 2014).   
In 2010, direct and indirect costs of cardiovascular disease and stroke equaled 
$315.4 billion in the United States, and it is estimated these health expenditures and lost 
productivity costs will continue to rise with the aging population (Go et al., 2014). 
Broken down, approximately $193.4 billion goes to direct costs including cost of 
physicians, hospital services, medications, and home health care; $122.0 billion goes to 
indirect costs, specifically loss of future productivity from early death (Go et al., 2014). 
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Furthermore, incidence and morbidity of cardiovascular disease conditions are increasing 
for this cohort with estimates suggesting 43.9% of the population of the United States is 
expected to have some form of cardiovascular disease by the year 2030. Additionally, 
both direct and indirect costs will increase substantially by 2030 with estimations 
upwards of 58% (Go et al., 2014). Direct costs from 2012-2030 are expected to rise to 
$918 billion with the majority attributed to hospital costs; furthermore, indirect costs will 
rise to $290 billion. Based on economic cost alone, primary prevention is critical for 
cardiovascular conditions, especially myocardial infarction, coronary heart disease or 
angina, and stroke (Charles & Zhang, 2012; Goldstein et al., 2011).  
To successfully prevent cardiovascular disease conditions such as myocardial 
infarction, coronary heart disease, and stroke, research must be done to identify risk 
factors e.g., modifiable and non-modifiable, that may precede these diseases. Established 
risk factors in the literature include: age, low birth weight, race/ethnicity, genetic 
factors/family history, obesity, gender, high blood pressure, diabetes, high cholesterol, 
unhealthy diet, physical inactivity, tobacco use, alcohol abuse, and depression (Grandner, 
Sands-Lincoln, Pak, & Garland, 2013; Hoevenaar-Blom, Kromhout, Berg, Spijkerman,  
& Verschuren, 2011; Sabanayagam & Shankar, 2010). Non-modifiable risk factors 
include age, race/ethnicity, and genetics/family history. Modifiable risk factors may 
include both co-morbid e.g. high blood pressure, diabetes, high cholesterol, depression, 
obesity; and behavioral factors e.g. unhealthy diet, physical inactivity, tobacco use, and 
alcohol abuse.  
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Prevalence risk factor statistics for age, gender, and cardiovascular conditions are 
as follows: for those aged 35-44 years, 3 per 1000 men will experience their first 
cardiovascular event versus, 74 per 1000 men aged 85-94 years old (Go et al., 2014). 
Although, women have similar rates with a 10 year delay, this disparity declines with 
increasing age. Furthermore, women have a higher proportion of events attributed to 
stroke, prior to 75 years of age, with men having an increased proportion of 
cardiovascular disease events caused by coronary heart disease. Cardiovascular 
prevalence statistics for race/ethnicity have established that Blacks have a higher 
prevalence of coronary heart disease (6.5%), hypertension (32.9%), and stroke (2.5%), 
compared to whites (6.1%, 22.9%, and 2.5% respectively) (Go et al., 2014). Concerning 
genetics/family history, the likelihood of a person having a heart attack increases with 
one or both parents having a heart attack and if they were younger or older than 50 years. 
For example, an individual with both parents who’ve had a heart attack younger than 50 
years of age are 6.56 times more likely to have a heart attack compared to those with no 
family history (OR= 6.56, CI=1.39, 30.95) (Go et al., 2014). Prevalence statistics in the 
United States for selected modifiable cardiovascular risk factors are as follows: 
approximately 78.4 million or 34.6% of adults in the U.S. are obese, and 98.9 million or 
43.4% have high cholesterol. Prevalence rates of high blood pressure is estimated at 77.9 
million or 33.0% U.S. adults with n=63,100 mortalities; 19.7 million or 8.3% adults have 
diabetes mellitus i.e. type II diabetes, with n=69,071 mortalities attributed to this disease 
(Go et al., 2014). Comparatively, 42.1 million or 18.1% of U.S. adults currently use 
tobacco, and an estimated 16 million (6.9%) suffer from depression.   
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Additionally, other modifiable risk factors not well established in the literature 
show inconsistent associations is of particular interest. For instance, epidemiological 
studies have observed strong associations with obstructive sleep disorders (OSD) and 
cardiovascular diseases indicating obstructive sleep apnea (OSA), and sleep disordered 
breathing (SBD), may be strong risk factors (Al Lawati, Patel, & Ayas, 2009; Arzt, 
Young, Finn, Skatrud, & Bradley, 2005; Butt, Dwivedi, Khair, & Lip, 2010; Wallace, 
Ramos, & Rundek, 2012).  Most notably, insufficient sleep was linked to numerous 
chronic diseases, and conditions. With more than one third of the United States 
population reporting less than 7 hours of sleep per night on average, deficient sleep may 
be associated with cardiovascular diseases and/or its conditions (CDC Fact Sheet, 2013).  
According to the National Sleep Foundation, the average adult needs between 7 
and 9 hours of sleep per day, yet in 2008, 28% adults in the United States reported having 
deficient sleep (MMWR, 2011). It’s estimated that 50-70 million adults in the U.S. have 
some form of a chronic sleep disorder, such as chronic insomnia, sleep talking or 
walking, sleep apnea, narcolepsy, and restless leg syndrome (MMWR, 2011). Almost one 
third of adults have additionally reported getting insufficient sleep the previous 14 days 
or more in the past 30 days. Ineffectual sleep can cause many negative side effects and 
can potentially be dangerous by increasing the risk of falling asleep at the wheel. Other 
potential dangers from inadequate sleep duration include causing an individual to have an 
increased BMI, and may potentially increase ones risk for depression, substance abuse, 
type II diabetes, and heart problems (National Sleep Foundation, 2014). Further research 
is needed to provide evidence for the effects sleep duration can cause, whether it be 
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deficient or excessive sleep (not in the average 7 to 9 hour range per night). This research 
will provide some evidence towards if an association truly exists between sleep duration 
and cardiovascular disease conditions. 
Literature Review 
In the current literature, both quality of sleep, and sleep duration studies have not 
observed consistent associations, and have shown uncertain causality with cardiovascular 
conditions such as myocardial infarction, coronary heart disease or angina, and stroke. 
Studies specifically for the state of Nevada are sparse, and are only included in 
conjunction with other states e.g. multi-state, population-based studies.  These multi-
state, population-based studies have shown short, and long sleep duration, is associated 
with known cardiovascular risk factors such as diabetes, hypertension, obesity, high 
cholesterol, depression, and overall metabolic dysfunction (Buxton & Marcelli, 2010; 
Hoevenaar-Blom et al., 2011; Khawaja, Sarwar, Albert, Gaziano, & Djoussé, 2013; 
Krueger & Friedman, 2009; Liu, Wheaton, Chapman, & Croft, 2013;). Additionally, 
deficient and excessive sleep deficiencies have shown associations with respiratory 
disorders, and overall, poor self-rated health (Aggarwal, Loomba, Arora, & Molnar, 
2013). However, less is known specifically about sleep duration, and its relation to 
cardiovascular diseases and its conditions, not its risk factors (Harvard Health Letter, 
2013). 
 Various studies have assessed associations between sleep duration versus sleep 
insufficiency and cardiometabolic outcomes, general sleep disturbance and 
cardiovascular diseases, daytime sleepiness as a risk factor for CVD, and sleep duration, 
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quality and CVD morality among the elderly (Altman et al., 2012; Grandner, Jackson, 
Pak & Gehrman, 2012; Gangwisch et al., 2014; Suzuki et al., 2009). Short and long sleep 
duration have both been variably cited as potential risk factors for cardiovascular 
diseases, yet an assorted studies repetitively state uncertain association and causality. A 
prospective and meta-analysis study examined short sleep duration, and cardiovascular 
disease; results found that those who slept less than 6 hours were not at risk for 
cardiovascular disease after adjustment, yet were at risk for incident type II diabetes 
(Holliday, Magee, Kritharides, Banks, & Attia, 2013). Another study showing less 
consistent results, found sleep duration as an independent risk factor for cardiovascular 
disease, and mortality for women, but not for men (Kronholm, Laatikainen, Peltonen, 
Sippola, & Partonen, 2011). 
Furthermore, inconsistent findings among studies have shown differing risks 
between sleep duration and various cardiovascular disease conditions. A cohort study in 
Sweden found short sleep duration to only be associated with myocardial infarction, 
whereas stroke was not significant (Westerlund et al., 2013). Conversely, a cohort in the 
United States found an association between short sleep duration and only stroke (Ruiter 
Petrov, Letter, Howard, & Kleindorfer, 2014). According to Aggarwal et al. (2013), short 
sleep duration was associated with stroke, myocardial infarction, and congestive heart 
failure, whereas more than 8 hours of sleep was associated with coronary artery disease 
and angina. Moreover, deficient and excessive sleep were both found to be associated 
with myocardial infarction and stroke in a study by Altman et al. (2012). Although these 
studies found associations between various cardiovascular disease conditions, as stated 
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previously, the study by Holliday et al. (2013), a combined meta-analysis and prospective 
cohort, found short sleep duration was not a risk for cardiovascular disease after 
adjustment, and only for diabetes mellitus.  The uncertain association between sleep 
duration and cardiovascular disease conditions in the literature shows the need for more 
confirmatory studies, specifically prospective cohort studies, in order to determine a true 
relationship.  
Research Objectives 
Given this ambiguity of the literature, this cross-sectional, population-based study 
utilizes the chronic health data from the 2013 Nevada Behavioral Risk Factor 
Surveillance System which includes data on cardiovascular disease conditions such as 
myocardial infarction, coronary heart disease or angina, and stroke. The primary 
objective of this study is to investigate the association between deficient and/or excessive 
sleep duration and myocardial infarction, coronary heart disease or angina, and stroke 
(i.e. cardiovascular disease conditions in adult Nevadans). The second objective of this 
study is to identify which demographic, co-morbid, and behavioral variables are 
associated with the combined cardiovascular condition variable. Once the significant 
variables from each of these groups have been identified, the significant variables will 
then be re-analyzed with the cardiovascular condition variable. Lastly, the remaining 
significant variables and deficient sleep (4 hours or less) and/or excessive sleep (10 hours 
or more) was determined to be associated with a cardiovascular condition i.e. myocardial 
infarction, coronary heart disease or angina, and stroke.   
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Research Questions 
Research Question #1: Is deficient sleep duration significantly associated with 
myocardial infarction, coronary heart disease or angina, and stroke (cardiovascular 
condition variable)? 
Hypothesis #1: 
 𝐻𝑂= Deficient sleep duration is not associated with myocardial infarction, 
   coronary heart disease or angina, and stroke     
 𝐻𝐴= Deficient sleep duration is associated with myocardial infarction, 
   coronary heart disease or angina, and stroke   
Expected Outcome:  
It is expected that deficient sleep duration will be significantly associated with 
myocardial infarction, coronary heart disease or angina, and stroke. 
Research Question #2: Is excessive sleep duration significantly associated with 
myocardial infarction, coronary heart disease or angina, and stroke (cardiovascular 
condition variable)? 
Hypothesis #1: 
 𝐻𝑂= Excessive sleep duration is not associated with myocardial infarction, 
   coronary heart disease or angina, and stroke .  
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 𝐻𝐴= Excessive sleep duration is associated with myocardial infarction, 
   coronary heart disease or angina, and stroke .  
Expected Outcome:  
It is expected that excessive sleep duration will be significantly associated with 
myocardial infarction, coronary heart disease or angina, and stroke. 
Research Question #3: Which demographic, co-morbid, and/or behavioral factors are 
significantly associated with myocardial infarction, coronary heart disease or angina, and 
stroke (cardiovascular condition variable)? 
Hypothesis #1: 
 𝐻𝑂= There are no demographic, co-morbid, and/or behavioral factors  
  associated with myocardial infarction, coronary heart disease or angina,  
  and stroke  
 𝐻𝐴= There are is at least one demographic, co-morbid, and/or behavioral  
  factors  associated with myocardial infarction, coronary heart disease or  
  angina, and stroke  
Expected Outcome:  
It is expected that one or more demographic, co-morbid, and/or behavioral factors 
will be significantly associated myocardial infarction, coronary heart disease or 
angina, and stroke.  
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Methodology 
Study Design and Sample 
 This study is a cross sectional, population-based study, that utilizes the 2013 
Nevada Behavioral Risk Factor Surveillance System (BRFSS). The BRFSS is a state-
based, random-digit dialed telephone survey that collects descriptive and health-related 
data annually in the United States. The health-related data obtained from the BRFSS 
includes risk behaviors, chronic health conditions, and the use of preventive services.  
Throughout the year, a standardized core questionnaire, along with optional modules, and 
state-added questions, are administered to willing participants.  
 Administration of the standardized core questionnaire takes approximately 18 
minutes, with an additional 5 to 10 minutes for additional modules and state-added 
questions. Management of the BRFSS by the state is achieved by way of a multi-faceted 
collaboration with various entities including the Centers for Disease Control (CDC), state 
health department agencies, telephone call centers, and participating universities. State 
health personnel or contractors conduct interviews by following specific rubric and 
guidelines given by the BRFSS.  In-depth details on the data, collection, documentation, 
and methodology of the BRFSS survey may be found on the Centers for Disease Control 
website.    
 The study population asked to participate in the BRFSS are adults aged 18 years 
or older, are voluntary participants who have the option to refuse or elect to complete the 
telephone survey, and are not institutionalized or incarcerated in care homes, outpatient 
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facilities, or prisons. The survey utilizes both landline telephones as well as cellular 
phone as of 2011. The BRFSS goal is to capture at least 4,000 interviews annually per 
each state. For the intended study year of 2013, the BRFSS obtained a total sample size 
of N=491,773 for all 50 states, in addition to British Columbia, and three U.S. territories. 
Completed interviews were estimated at N=433,220 whereas, N=58,553 were partial 
interviews. For this study, the state of Nevada in 2013 achieved a sample size of 
N=5,101; approximately 1.04% of the total sample size of the BRFSS.        
Variables  
To obtain the dependent variable for a cardiovascular disease (CVD) condition, 
three dichotomous variables were combined. These dependent variables (DV) include: 
heart attack, coronary heart disease or angina, and stroke (Appendix A). The three 
variables are defined as yes, or no, with the questions following the format “Has a doctor, 
nurse or other health professional ever told you that you had any of the following?”, and 
“Ever told you had …a heart attack, coronary heart disease or angina, a stroke?” The 
dependent variables were transformed into one variable; if the survey participant said yes 
to having any of these three variables, they were considered having a cardiovascular 
disease condition.  
The independent variables (IV) incorporated into the analysis were divided into 
three individual models for the purpose of running a multiple regression model. These 
three models include a demographic model, a co-morbid model, and a behavioral model. 
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Furthermore, a final significant variable model was ran with all of the significant 
variables determined from the previous models in order to reduce collinearity bias.  
The independent variables (IV) in the demographic model include: sex, 
race/ethnicity, age, marital status, education, and health insurance coverage. The variable 
‘sex’ is dichotomous and is defined as male or female. The variable ‘race’ is categorical 
and characterized as white, black, Hispanic, other race and multi-racial. Other race is 
defined as those of Asian or Native Hawaiian/ Pacific Islander, American Indian/Alaska 
Native, descent. ‘Age’ is categorical and was grouped by 18-34 years, 35-44 years, 45-64 
years, and 65 years and older. ‘Marital status’ is categorical and characterized as married, 
divorced, widowed, separated, never married, and a member of an unmarried couple. 
Never married and a member of an unmarried couple were combined. ‘Education’ is 
categorical and grouped by did not graduate high school, graduated high school, attended 
college or technical school, and graduated college or technical school. ‘Health insurance 
coverage’ is dichotomous and is defined as yes or no for being currently covered by any 
health insurance or coverage plans.  
The independent variables (IV) in the co-morbid model include: hypertension, 
high cholesterol, diabetes, depression, and BMI.  The variable ‘hypertension’ or as 
having high blood pressure is dichotomous and is defined as yes or no with the question 
“Ever told you have high blood pressure”. The variable ‘high cholesterol’ is dichotomous 
and is defined as yes or no with the question “Ever told you have high cholesterol”. The 
variable ‘diabetes’ is dichotomous and is defined as yes or no with the question “Ever 
told you have diabetes”. The variable ‘depression’ is dichotomous and is defined as yes 
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or no with the question “Ever told you have a depressive disorder including depression, 
major depression, dysthymia, or minor depression”. The variable ‘BMI” was re-coded 
from a categorical variable to a dichotomous variable. BMI was then defined as adults 
who are obese or adults who are under, normal, or overweight.  
The independent variables (IV) in the behavioral model include: inadequate sleep, 
cigarette smoking, heavy drinking, physical activity, and diet. The variable ‘inadequate 
sleep’ is continuous and is defined as number of hours with the question “On average, 
how many hours of sleep do you get in a 24 hour period”. Sleep duration was then re-
coded as a categorical variable with four categories: 1-4 hours of sleep, 5-6 hours of 
sleep, 7-9 hours of sleep, and 10-18 hours of sleep. The cutoffs for sleep duration were 
decided based on the inconsistencies of sleep duration in the literature. The most effectual 
average amount of sleep per night is defined as 7-9 hours by the National Sleep 
Foundation, and therefore, it was intuitive to cutoff at 6 and 10 hours. The subgroup 1-4 
hours and 10-18 hours are considered extreme sleep patterns, versus the subgroup 5-6 
hours which has been unpredictably grouped with 7-9 hours in various literatures. 
Therefore, separating 5-6 hours of sleep, and 7-9 hours of sleep, follows the guidelines 
from the National Sleep Foundation, the leading educational and scientific non-profit 
organization for sleep education and advocacy.   
The variable ‘cigarette smoking’ is dichotomous and is defined as yes or no with 
the question “Do you smoke every day and/or some days or not at all”. Cigarette smoking 
was re-coded by the BRFSS into a categorical variable with three categories: never 
smoked, former smoker, and current smoker. The variable ‘heavy drinking’ is 
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dichotomous and asks how often men and women indulge in alcoholic drinks per day. If 
adult men answered two or more drinks per day and/or adult women answered one or 
more drinks per day, these participants were labeled as ‘yes’ to heavy drinking. If they 
did not meet the alcohol drink standard of two or more per day for men or one or more 
per day for women, they were labeled as ‘no’. The variable ‘physical activity’ is 
categorical and defined as meeting both  aerobic and strength recommendations, meeting 
only aerobic recommendation only, meeting strength recommendation only, and did not 
meet either recommendation. The variable selected for diet was ‘dark green vegetable 
intake per day’. This variable is continuous and poses the question ‘ During the past 
month, how many times per day, week or month did you eat dark green vegetables for 
example broccoli or dark leafy greens including romaine, chard, collard green or 
spinach?”. A computed variable for the daily intake of dark green vegetables was 
derived.  
Weighting the Sample  
 Beginning in 2011, cellular telephones were added to the sample to maintain 
generalizability, coverage, and validity in the BRFSS. Due to the inclusion of both 
cellular and landline telephones in the sample, the CDC changed from the statistical 
method of post stratification (utilized since the 1980’s) to a new weighting method called 
iterative proportional fitting, or raking. Post stratification allowed data to be weighted to 
known proportions of age, race, ethnicity, sex, and geographic region within a 
population. Raking, the new weighting technique utilized, is more advantageous by 
allowing the incorporation of more demographic variables into the weighting process 
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such as education level, marital status, and home ownership; in addition, the weighting 
methodology may now incorporate landline and cellular telephone use, thus reducing bias 
and increasing generalizability in the sample. Ideally, groups that are underrepresented in 
the sample were more accurately represented after raking adjusted the data set.  
 To continue, unweighted data violates assumptions by assuming all individuals 
have an equal probability of being selected from the population and individuals who did 
not respond were the same to those who did respond. These violation of assumptions 
were found to greatly affect data sets, and therefore, weighting each individual record is 
needed to adjust for this. For a state population, such as Nevada, weighting adjusts for 
both non-response individuals, and individuals who were not covered. In addition, it 
makes the cases secured equal to the population estimates for each of the geographic 
regions. Without this, the data sample collected annually cannot be generalized to the 
main population.  
 For 2013, the weighted raking methodology is comprised of both design weight 
and raking; design weight reduces bias due to the unequal probability of selection by 
setting values to 1, and raking adjusts for demographic differences between persons who 
are sampled and the populations from which the samples came from. Design weight is 
calculated by using the weight of each geographic stratum, the number of landline phones 
within a household, and the number of adults who use those phones. Cell phone 
participants utilize the same equation except that the number of landline phones within a 
household and the number of adults who use the phones are set to 1. To further explain, 
cell phone participants are identified during the design weighting process as being a 1 
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adult and 1 phone household, whereas a landline participant could have more than 1 adult 
and more than 1 phone in a household.  
Design weight takes into account the number of phones in a household, the 
number of adults in a household the number of available records, and the number of 
records selected within each geographic strata and density strata. Before the design 
weight can be calculated, the stratum weight (_STRWT) must be calculated within each 
geographic strata (_GEOSTR) and density strata (_DENSTR). Weighting variables and 
their complete definitions can be found in Appendix C.  
STRWT= NRECSTR/NRECSEL  
STRWT= Stratum weight 
NRECSTR = number of available records 
NRECSEL= number of records selected  
Design weight = STRWT * (1/NUMPHON2) * NUMADULT 
STRWT = Stratum weight 
NUMPHON2 = Number of landline phones within a household 
NUMADULT = Number of adults who use the landline phones within a household 
_LLCPWT = the final weight assigned to each respondent  
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Statistical Analysis   
 Data from the 2013 BRFSS was analyzed using the statistical software SPSS 
version 20 with an add-on for complex samples. A sample plan was then created to use 
complex samples and three weighting variables from the data set were selected. These 
three weighting variables include: _STSTR, _PSU, and _LLCP_WGT and were placed 
into the categories of Strata, Cluster, and Weight, respectively.   
Descriptive analysis of frequencies and cross tabs by Rao Scott χ2 test were run. 
The Rao Scott χ2 test is an adjusted chi-square that is utilized to compare weighted 
percentages and shows which independent variables have different distributions for the 
dependent variable. The Rao Scott χ2 test statistics include: an adjusted Pearson chi-
square, a Likelihood ratio, an adjusted F, degrees of freedom, and significance set at p < 
0.05.  Multiple logistic regression, similar to linear regression, was utilized to describe 
the relationship between the outcome variable and independent variables. Moreover, it’s 
well-suited for models where the outcome variable, or dependent variable, is 
dichotomous. A stepwise or “block” approach was implemented during analysis; the 
models described earlier under ‘Variables’ were delineated as individual blocks. Each 
block will have the combined cardiovascular condition variable as its outcome variable, 
and the independent variables will be divided into a demographic block, a co-morbid 
block, a behavioral block, and a final significant variable block. The grouping of these 
factors into individual blocks is based on the perception of modifiable and non-
modifiable risk factors for cardiovascular disease and its conditions. Applying the block 
approach to the multiple logistic regression analysis will also decrease the chance of 
19 
 
flooding the models i.e. the kitchen sink effect, and reduce collinearity bias among 
variables. Furthermore, merging the cardiovascular conditions i.e. myocardial infarction, 
coronary heart disease or angina, and stroke, into one binary dependent variable allows 
for a more robust sample, and increases the power of the analyses. Odds ratios (OR) and 
confidence intervals (CI) are obtained from the multiple logistic regression model with 
significance set at p < 0.05, and  95% CI. Lastly, the cut off for variable inclusion in the 
final significant model was p < 0.095 in regression analyses.   
Prior to this research, CITI Human Subjects: Social and Behavioral Research 
training, and Center for Online Medical Education and Training (COMET) through 
Cleveland Clinic was completed. Additionally, the BRFSS data were de-identified prior 
to analysis. For the BRFSS survey, informed consents were not collected during the 
telephone interview due to the de-identification process. For states with add-on modules 
regarding questions for children, informed consent is needed. This thesis did not analyze 
questions from these childhood add-on modules. The BRFSS data set is available for 
public use on the Centers for Disease Control website and is exempt from the UNLV 
Institutional Review Board (IRB).  
Results 
Demographics 
 The data set for the state of Nevada identified a total of N=5,102 individuals who 
participated in the 2013 BRFSS. Of the 5,102 individuals who participated,   n=2,195 
were reportedly male with a weighted percent of 50.2%, whereas n=2,907 were female 
20 
 
with a weighted percent of 49.8% (Table 1). Those aged 45-64 years old consisted mostly 
of the sample with a weighted 33.9%, followed by those aged 18-34 years old with a 
weighted 30.4%. Both those aged 35-44 years, and 65 years or older, did not exceed one 
fifth of the sample (17.6%, 18.1% respectively). The majority of participants were white 
with a weighted 56.1%; Hispanics came in second with a weighted 24.4%. Over half of 
the participants of the survey were married (50.4%), whereas participants identifying as 
never married consisted of more than a quarter (26.8%). Approximately one-third of the 
sample attended college or technical school, closely followed by individuals graduated 
high school only (33.6%, and 29.5%).  As for health insurance, an overwhelming 
majority of those whom participated in this study had some form of insurance, whether it 
was government or private, with a weighted 94.7%, while only 5.3% reported no health 
insurance (Table 1).  
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 Table 1: Descriptive Statistics for the State of Nevada, BRFSS 2013 (N=5,102) 
Variable  Unweighted (n) Weighted % 
Gender       
  Male 2195 50.2% 
  Female 2907 49.8% 
Age       
  18-34 years old 895 30.4% 
  35-44 years old 631 17.6% 
  45-64 years old 1915 33.9% 
  65 years and older 1607 18.1% 
Race       
  White 3744 56.1% 
  Black 187 7.7% 
  Other race 259 9.9% 
  Multi-racial 218 1.9% 
  Hispanic 611 24.4% 
Marital        
  Married 2480 50.4% 
  Divorced 912 13.4% 
  Widowed 618 6.6% 
  Separated 129 2.8% 
 Never Married 930 26.8% 
Education       
  Did not graduate High School 356 17.1% 
  Graduated High School 1375 29.5% 
  Attended College/Tech School 1728 33.6% 
  Graduated College/Tech School 1626 19.9% 
Insurance       
  Yes Insurance 4727 94.7% 
  No Insurance 327 5.3% 
 
 
 From the 2013 BRFSS sample, only 4.4% of participants reported having a 
myocardial infarction (MI) event, while the majority of participants (95.6%) did not. Less 
than 4% of the sample were diagnosed by a physician or health care provider with 
coronary heart disease or had angina; 96.6% had neither conditions (Table 2). Nearly 3% 
of the sample reported a stroke event, whilst the remaining did not (2.9% versus 97.1%). 
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These combined dependent variables to make the dichotomous ‘cardiovascular condition 
variable’ allowed for a more robust sample, with approximately 8.4% of the sample 
reporting as having one of the above conditions (n=499), and less than 92% as having 
none of these conditions (n=4463) (reported in Table 2).  
 The prevalence of selected co-morbid risk factors for the state of Nevada can be 
found in Table 3. Of the 5,102 individuals who participated, n=3,176 reported as having 
normal blood pressure (68.8%), versus n=1,1915 reported as having high blood pressure 
(31.2%). For high cholesterol, 38.6% responded yes, whereas a weighted 61.4% 
responded as having normal cholesterol levels. Ten percent of participants were 
diagnosed with diabetes, while the vast majority of the sample (89.7%) was non-diabetic. 
Similarly, those suffering from a depressive disorder accounted for less than one fifth of 
the population (17.6%) (Table 3). Participants identified as being under weight, normal 
weight, or over weight made up almost three fourths (73.8%), in conjunction with obese 
participants whom made up slightly more than a quarter (26.2%) of the sample.   
 The prevalence of selected behavioral risk factors for the state of Nevada can be 
found in Table 4. For physical activity, 38.5% of individuals did not reach either aerobic 
or strength recommendations, followed by 29.5% whom met aerobic recommendations 
only. Individuals who met both recommendations for aerobic and strength accounted for 
22.8% of the sample, and lastly, 9.3% only met the strength recommendations (Table 4). 
For tobacco smoking, more than half of the sample reported never smoked (58.1%), and 
both former, and current smokers accounted for nearly a fourth each (22.5%, 19.4% 
respectively). As for heavy consumption of alcohol, 93.0% of the sample were 
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purportedly not heavy drinkers, with the remaining 7.0% reporting consumption of more 
than two alcoholic beverages per day on average. Sleep duration, the variable of interest 
in this study, had a prevalence of 61.8% individuals who sleep 7-9 hours on average, 
followed by 31.5% who sleep 5-6 hours. Both outlying sleep duration hours e.g. 1-4 
hours, and 10-18 hours, accounted for less than 7% of the sample (3.8%, and 2.8% 
respectively).   
 
Table 2: Prevalence of Dependent Variables and Combined Outcome 
Variable for the State of Nevada, BRFSS 2013 (N=5,102) 
Variable  Unweighted (n) Weighted % 
Myocardial infarction (MI) 
  No MI event 4768 95.6% 
  Yes MI event 314 4.4% 
Coronary heart disease (CHD) or angina 
  No CHD or angina 4782 96.6% 
  Yes CHD or angina 281 3.4% 
Stroke 
  No stroke event 4865 97.1% 
  Yes stroke event 218 2.9% 
Combined Cardiovascular (CVD) Condition variable 
  No CVD condition 4463 91.6% 
  Yes CVD condition 599 8.4% 
Cardiovascular conditions include myocardial infarction, coronary heart disease or angina, 
and stroke. 
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Table 3: Prevalence of Selected Co-morbid Factors for the State of Nevada, 
BRFSS 2013 (N=5,102) 
Variable  Unweighted (n) Weighted % 
Blood Pressure 
  No high blood pressure 3176 68.8% 
  Yes high blood pressure 1915 31.2% 
Cholesterol 
  No high cholesterol  2439 61.4% 
  Yes high cholesterol 1798 38.6% 
Diabetes 
  No diabetes  4537 89.7% 
  Yes diabetes  551 10.3% 
Depression 
  No depressive disorder 4129 82.4% 
  Yes depressive disorder 947 17.6% 
BMI 
  Under/normal/over weight 3633 73.8% 
  Obese 1239 26.2% 
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Table 4: Prevalence of Selected Behavioral Factors for the State of Nevada, 
BRFSS 2013 (N=5,102) 
Variable  Unweighted (n) Weighted % 
Physical Activity 
  Met aerobic and strength rec.  970 22.8% 
  Met aerobic rec. only 1390 29.5% 
  Met strength rec. only 323 9.3% 
  Did not meet either rec. 1603 38.5% 
Dark Green Vegetable intake per day 
  Continuous variable  N/A N/A 
Sleep Duration 
  1-4 hrs of sleep 185 3.8% 
  5-6 hrs of sleep 1478 31.5% 
  7-9 hrs of sleep 3183 61.8% 
  10-18 hrs of sleep 190 2.8% 
Smoking 
  Never smoked  2643 58.1% 
  Former smoker 1454 22.5% 
  Current smoker 888 19.4% 
Heavy Drinking 
  No heavy drinking  4509 93.0% 
  Yes heavy drinking 384 7.0% 
 
 
Rao-Scott Adjusted χ 2 
 The Rao Scott adjusted chi-square examined the significance of relationships 
between the dependent cardiovascular condition variable e.g. myocardial infarction, 
coronary heart disease or angina, and stroke, and various independent variables. Table 5 
highlights which independent variables show a statistically significant difference in the 
proportion of individuals who have had a cardiovascular condition. Of the demographic 
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variables, age, race, marital status, and insurance had significantly different proportions; 
gender, and education were not statistically significant (p=0.286, and 0.336, 
respectively).  Of the co-morbid variables, all variables except BMI (p=0.090), reached 
statistical significance including high blood pressure, high cholesterol, diabetes, and 
depression (p value < 0.05). Sleep duration, smoking, and physical activity are the 
behavioral variables that reached significance (Table 5). Heavy drinking was approaching 
statistical significance (p=0.065), as well as daily intake of dark green vegetables 
(p=0.088).  
 
Table 5: The Rao-Scott adjusted χ2 for Cardiovascular Conditions and Selected 
Factors including Demographic, Co-Morbid, and Behavior Variables 
    χ2   P 
Demographic 
Variables 
Age 49.23 Ԍ-statistic 0.0001 
Gender 1.140 χ2 0.286 
Race 4.742 Ԍ-statistic 0.001 
Marital status 14.247 Ԍ-statistic 0.0001 
Education 1.122 Ԍ-statistic 0.336 
Insurance 18.476 χ2 0.0001 
Co-morbid Variables High blood pressure 172.089 χ2 0.0001 
High cholesterol 53.128 χ2 0.0001 
Diabetes 69.72 χ2 0.0001 
Depressive Disorder 25.128 χ2 0.0001 
BMI 2.867 χ2 0.090 
Behavior Variables Sleep duration 10.439 Ԍ-statistic 0.0001 
Smoking 15.367 Ԍ-statistic 0.0001 
Heavy drinking 3.395 χ2 0.065 
Physical activity 5.009 Ԍ-statistic 0.002 
Dark green vegetables 1.375 Ԍ-statistic 0.088 
Cardiovascular conditions include myocardial infarction, coronary heart disease or angina, and 
stroke. 
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Furthermore, the Rao-Scott adjusted chi-square gives additional information 
including the estimated sample size and percent of each variable for those that did or did 
not have a cardiovascular condition. For the variable ‘age’, of those that had a CVD 
condition, 3.7% were aged 18-34 years, 10.5% were aged 35-44 years, 37.7% were aged 
45-64 years, and 48.1% were aged 65 years and older (Table 6). For the variable 
‘gender’, of those that had a condition, 53.8% were male, and 46.2% were female.  For 
the variable ‘race’, of those that had a condition, 67.2% are white, 10.6% are black, 5.8% 
are identified as other race, 2.1% are multi-racial, and 14.3% are Hispanic.  
Continuing with co-morbid variables, of those who had a cardiovascular 
condition, 71.6% have high blood pressure, 63.3% have high cholesterol, 28.7% are 
diabetic, 30.9% suffer from a depressive disorder, and 31.4% are obese (Table 6). 
Additionally, of those participants who had reported a CVD condition, only 15.3% met 
the aerobic and strength recommendations, 28.5% met the aerobic recommendation only, 
6.0% met the strength recommendation only, and 50.2% did not meet either 
recommendations for aerobics or strength training. As for those having a cardiovascular 
condition, and the variable ‘sleep duration’, 7.1% reported 1-4 hours of sleep, 27.1% 
reported 5-6 hours of sleep, 56.3% reported 7-9 hours of sleep, and 9.6% reported 10-18 
hours of sleep a night. Moreover, of the participants whom had a CVD condition, 40.1% 
never smoked, 13.9% are former smokers, and 23.3% are currently smokers. Lastly, of 
those whom had a condition, 4.2% of these individuals answered yes to heavy drinking.  
 
28 
 
 
Table 6: Estimated Frequencies of Selected Factors Within a Cardiovascular 
Condition vs. Within No Cardiovascular Condition 
Variable  n (%)  
No Condition  
 n(%)  
Yes Condition 
Age 18-34 years old 880 (33%) 11 (3.7%) 
35-44 years old 595 (18.4%) 34 (10.5%) 
45-64 years old 1736 (33.6%) 170 (37.7%) 
65 years and older 1207 (15.1%) 377 (48.1%) 
Gender Male 1880 (49.8%) 297 (53.8%) 
Female 2583 (50.2%) 302 (46.2%) 
Race White 3251 (55.1%) 467 (67.2%) 
Black 156 (7.4%) 30 (10.6%) 
Other race 229 (10.3%) 27 (5.8%)  
Multi-racial 186 (1.9%) 28 (2.1%) 
Hispanic 565 (25.4%) 42 (14.3%) 
Blood Pressure Yes high blood pressure 1461 (27.2%) 427 (71.6%) 
Cholesterol Yes high cholesterol 1410 (35.7%) 371 (63.3%) 
Diabetes Yes diabetes 382 (8.5%) 164 (28.7%) 
Depression Yes depression 758 (16.2%) 170 (30.9%) 
BMI Yes obesity 1048 (25.7%) 181 (31.4% 
Physical Activity Met aerobic & strength rec. 893 (23.6%) 75 (15.3%) 
  Met aerobic rec. only 1218 (29.6%) 158 (28.5%) 
  Met strength rec. only 282 (9.6%) 38 (6.0%) 
  Did not meet either rec. 1353 (37.2%) 235 (50.2%) 
Sleep Duration 1-4 hrs of sleep 139 (3.5%) 44 (7.1%) 
  5-6 hrs of sleep 1298 (31.9%) 168 (27.1%) 
  7-9 hrs of sleep  2840 (62.3%) 323 (56.3%) 
  10-18 hrs of sleep 132 (2.2%) 52 (9.6%) 
Smoking Never smoked  2411 (59.9%) 216 (40.1%) 
  Former smoker 1189 (21.2%) 253 (13.9%) 
  Current smoker 756 (18.9%) 122 (23.3%) 
Heavy Drinking Yes heavy drinking  351 (7.3%) 30 (4.2%) 
Cardiovascular conditions include myocardial infarction, coronary heart disease or angina, and 
stroke. 
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Demographic Factors Associated with Cardiovascular Condition  
 For multiple logistic regression analysis, reference categories for the demographic 
variables were chosen based on the greatest number of cases for each variable with the 
exception of age. After adjusting for  age, race, marital status, education, and insurance, 
males were found to be 1.34 times more likely to have myocardial infarction, coronary 
heart disease or angina, and stroke, compared to females, although this did not reach 
statistical significance (OR=1.343, CI=0.983, 1.835). However, the variable ‘gender’ 
approached significance with a p=0.064, and will be added to the final significant 
variable model with a liberal cutoff of p=0.095. For age, 65 years and older was chosen 
as the referent category for purposes of a cleaner odds ratio (OR). After adjusting for  
gender, age, race, marital status, education, and insurance, those aged 18-34 years were 
95.8% less likely to have myocardial infarction, coronary heart disease or angina, and 
stroke compared to those aged 65 years and older (OR=0.042, CI= 0.017, 0.105). Those 
aged 35-44 years were 78% less likely to have a condition, whereas 45-64 year olds were 
59.1% less likely than individuals 65 years and older, both with a significant p value less 
than 0.05 (Table 7).  
 For race/ethnicity, whites were used as the reference category. After adjustment, 
blacks were 1.2 times more likely than whites to have a condition, although this did not 
reach statistical significance (OR=1.237, CI=0.640, 2.394). The variable race and its 
subgroups were not statistically significant (p=0.492) and were not added in the final 
model. Marital status, education, nor insurance reached statistical significance and are 
therefore, excluded from the final model (p=0.722, p=0.439, and p=0.441 respectively).  
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This demographic regression model, according to Nagelkerke’s R-square value, was able 
to explain 16.3% of the variability for a cardiovascular condition. R square values for the 
regression models can be seen in Appendix D, Table 1.  
Table 7: Multiple Logistic Regression Analysis with Demographic Factors and 
Cardiovascular Conditions (N=5,102) 
Variable   OR CI P  
Gender       0.064 
  Female (ref.)       
  Male 1.343 (0.983, 1.835)   
Age        0.0001 
  18-34 years   0.042 (0.017, 0.105) * 
  35-44 years 0.22 (0.123, 0.396) * 
  45-64 years 0.409 (0.282, 0.593) * 
  65 years and older (ref.)       
Race 0.492 
  White (ref.)       
  Black 1.237 (0.640, 2.394)   
  Other Race 0.64 (0.314, 1.304)   
  Multi-racial 0.793 (0.386, 1.630)   
  Hispanic 0.672 (0.357, 1.262)   
Marital  0.722 
  Married (ref.)       
  Divorced 1.212 (0.813, 1.808)   
  Widowed 1.327 (0.846, 2.080)   
  Separated 1.268 (0.553, 2.909)   
 Never Married 1.194 (0.656, 2.175)  
Education 0.439 
  Graduated High School (ref.)       
  Did not graduate High School  1.42 (0.799, 2.523)   
  Attended College/Tech School 1.235 (0.865, 1.763)  
  Graduated College/Tech School 1.001 (0.681, 1.471)   
Insurance 0.441 
  Yes Insurance (ref.)       
  No Insurance 1.294 (0.671, 2.497)   
Cardiovascular conditions include myocardial infarction, coronary heart disease or angina, and 
stroke. * indicates p value < .05 
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Co-Morbid Factors Associated with a Cardiovascular Condition 
 For multiple logistic regression analysis, the referent category for the co-morbid 
variables are the subgroups delineated as ‘without the disease or condition’ (Table 8). 
After adjustment for all variables included in the block, individuals who said ‘yes’ to 
having high blood pressure are 3.67 times more likely to have had a myocardial 
infarction, coronary heart disease or angina, and stroke compared to those who have 
normal blood pressure (p < .0001). Furthermore, those with high cholesterol were 2.32 
times more likely to have had a condition with a statistically significant p value < .0001 
(OR=2.32, CI=1.645, 3.272).  Diabetic persons were almost two fold times more likely to 
have a cardiovascular condition and was also statistically significant in the model 
(p=0.003). In addition, those suffering from a depressive disorder were 1.8 times more 
likely to have a cardiovascular condition compared to those who do not (OR=1.786, 
CI=1.228, 2.598).  
 Depressive disorders added significantly to the model with a p=0.002 (Table 8). 
In contrast, obese participants were protected against having a cardiovascular condition 
(OR=0.61, CI=0.416, 0.893) compared to those who are under weight, normal weight, or 
over weight (p=0.011). This co-morbid regression model, according to Nagelkerke’s R-
square value, was able to explain 17.3% of the variability for a cardiovascular condition. 
R square values for the regression models can be seen in Appendix D, Table 2. Lastly, all 
five co-morbid variables in this model met the liberal cutoff of p=0.095, and hence, are 
included in the final significant variable model.  
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Table 8: Multiple Logistic Regression Analysis with Co-Morbid Factors and 
Cardiovascular Conditions (N=5,102) 
Variable  OR  CI  P  
Blood Pressure 0.0001 
  No high blood pressure (ref.)       
  Yes high blood pressure 3.677 (2.526, 5.353) * 
Cholesterol 0.0001 
  No high cholesterol (ref.)       
  Yes high cholesterol 2.320 (1.645, 3.272) * 
Diabetes 0.003 
  No diabetes (ref.)       
  Yes diabetes  1.971 (1.259, 3.085) * 
Depression 0.002 
  No depressive disorder (ref.)       
  Yes depressive disorder 1.786 (1.228, 2.598) * 
BMI       0.011  
  Under/normal/over weight (ref.)      
  Obese 0.61 (0.416, 0.893)  * 
Cardiovascular conditions include myocardial infarction, coronary heart disease or angina, 
and stroke. * indicates p value < .05 
 
 
Behavioral Factors Associated with a Cardiovascular Condition 
 For multiple logistic regression analysis, the referent category for the behavioral 
variables are the subgroups labeled ‘ref.’ found in Table 9. After adjustment, the variable 
‘physical activity’ approached statistical significance with a p value of 0.067, yet only 
one subcategory among three was found to be significant. Physical activity subcategory 
‘did not meet either recommendation’ for aerobics or strength activities was significant 
with an increased odds of having a cardiovascular condition compared to the referent 
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(OR=1.688, CI=1.053, 2.706). Dark green vegetable intake per day, a continuous 
variable, was approaching significance with p=0.095 (Table 9). Sleep duration, the 
principle variable of interest for this thesis, was found statistically significant (p < .0001), 
as well as two of its subgroups: deficient sleep and excessive sleep. Those who slept 1-4 
hours a night were 2 times more likely to have myocardial infarction, coronary heart 
disease or angina, and stroke, compared to those who slept 7-9 hours a night (OR=2.013, 
CI=1.093, 3.707). In comparison, those who slept 10-18 hours a night were 6.2 times 
more likely to have had a condition, in contrast to the referent group who on average, had 
7-9 hours of sleep at night (OR=6.242, CI=3.511, 11.09).  The variable ‘smoking’ and 
both its subgroups were found statistically significant with a p < .0001 (Table 9).  
 Former smokers were 2.6 times more likely to have a cardiovascular condition, 
whereas current smokers were 1.7 times more likely than their ‘never smoked’ 
counterparts (OR=2.573, CI=1.766, 3.749; OR=1.728, CI=1.079, 2.719). The variable 
‘heavy drinking’ was found to be protective with those who drank, on average, two 
drinks or more a night were 61.5% less likely to have a condition (OR=0.385, CI=0.202, 
0.734). Moreover, heavy drinking added to the model significantly with p=0.004 (Table 
9). According to Nagelkerke’s R-square value, this behavioral regression model was able 
to explain only 9.0% of the variability for a cardiovascular condition and can be found in 
Appendix D, Table 3.  Although only three behavioral variables were statistically 
significant (p < 0.05), both physical activity and dark green vegetable intake per day met 
the liberal cutoff (p=0.095) and will be included in the final significant variable model.  
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Table 9: Multiple Logistic Regression Analysis with Behavioral Factors and 
Cardiovascular Conditions (N=5,102) 
Variable  OR  CI  P  
Physical Activity 0.067 
  Met aerobic & strength rec. (ref.)       
  Met aerobic rec. only 1.322 (0.815, 2.144)   
  Met strength rec. only 0.897 (0.442, 1.820)   
  Did not meet either rec. 1.688 (1.053, 2.706) * 
Dark Green Vegetable intake per day 0.095 
  Continuous variable        
Sleep Duration 0.000 
  1-4 hours of sleep 2.013 (1.093, 3.707) * 
  5-6 hours of sleep 1.074 (0.720, 1.601)   
  7-9 hours of sleep (ref.)       
  10-18 hours of sleep 6.242 (3.511,  11.09) * 
Smoking 0.000 
  Never smoked (ref.)       
  Former smoker 2.573 (1.766, 3.749) * 
  Current smoker 1.728 (1.097, 2.719) * 
Heavy Drinking       0.004 
  No heavy drinking (ref.)       
  Yes heavy drinking 0.385 (0.202, 0.734) * 
Cardiovascular conditions include myocardial infarction, coronary heart disease or angina, and 
stroke. * indicates p value < .05 
 
 
Final Significant Variable Model  
 For the final multiple logistic regression model, the referent subgroups from 
previous blocks will remain the same and will be labeled ‘ref.’ in Table 10. Twelve 
formerly significant variables have been included in this final model: gender, age, high 
blood pressure, high cholesterol, diabetes, depression, BMI, physical activity, sleep 
duration, smoking, heavy drinking, and dark green vegetable intake per day. After 
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adjusting for all twelve variables added to the final model, a total of six variables reached 
statistical significance with a p <0.05. The significant variables found were age, high 
blood pressure, high cholesterol, depression, sleep duration, and heavy drinking (Table 
10). For ‘age’, the subgroup 18-34 years old were 91.1% less likely to have a condition 
compared to 65 years and older (OR=0.089, CI=0.029, 0.272). Those aged 35-44 years 
were 80% less likely to have a condition, and those aged 45-64 years were 58% less 
likely versus the referent group (OR=0.201, CI=0.085, 0.477; OR=0.420, CI=0.280, 
0.630). Individuals with high blood pressure were 2.4 times more likely to have a 
cardiovascular condition compared to those with normal blood pressure (p < .0001), 
whereas those with high cholesterol were 1.8 times more likely (p=0.002).  
 For the variable ‘depression’, those with a depressive disorder were 1.65 times 
more likely to have had a myocardial infarction, coronary heart disease or angina, and 
stroke (p=0.027). Participants who drank heavily on average were found to be protected 
again with a p value of 0.030 (Table 10). Based on the odds, this subgroup is 54.1% less 
likely to have a cardiovascular condition compared to those who do not heavily drink 
(OR=0.459, CI=0.227, 0.929). Sleep duration, the main focus of this study, was 
statistically significant with a p value < .0001, and the same two subgroups from the 
previous block have remained significant as well. Individuals who get a deficient amount 
of sleep e.g. 1-4 hours a night, are 2.4 times more likely to have a cardiovascular 
condition compared to the average of 7-9 hours of sleep a night (OR=2.412, CI=1.139, 
5.107). As for individuals who sleep excessively e.g. 10-18 hours a night, they were 
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nearly 7.2 times more likely to have a condition, versus the individuals who receive a 
normal night’s sleep (OR=7.170, CI=3.284, 15.654).   
 Both diabetes and gender had approached significance with a p value less than 
0.1, whereas BMI, physical activity, smoking, and dark green vegetable intake exceeded 
the liberal cutoff by at least 2-fold. Lastly, Nagelkerke’s R-square value was calculated 
for this final model and was able to explain 26.4% of the variability for a cardiovascular 
condition i.e. for myocardial infarction, coronary heart disease or angina, and stroke 
(Appendix D, Table 4).  
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Table 10: Multiple Logistic Regression Analysis with Final Significant Factors and 
Cardiovascular Conditions (N=5,102) 
Variable   OR CI P  
Gender       0.099 
  Female (ref.)       
  Male 1.391 (0.940, 2.059)   
Age        0.000 
  18-34 years  0.089 (0.029, 0.272) * 
  35-44 years 0.201 (0.085, 0.477) * 
  45-64 years 0.420 (0.280, 0.630) * 
  65 years and older (ref.)       
Blood Pressure 0.000 
  No high blood pressure (ref.)       
  Yes high blood pressure 2.407 (1.558, 3.717) * 
Cholesterol 0.002 
  No high cholesterol (ref.)       
  Yes high cholesterol 1.855 (1.251, 2.751) * 
Diabetes 0.089 
  No diabetes (ref.)       
  Yes diabetes  1.546 (0.936, 2.554)   
Depression 0.027 
  No depressive disorder (ref.)       
  Yes depressive disorder 1.655 (1.060, 2.584) * 
BMI       0.252 
  Under/normal/over weight (ref.)       
  Obese 0.785 (0.518, 1.188)   
Physical Activity 0.854 
  Met aerobic & strength rec. (ref.)       
  Met aerobic rec. only 0.922 (0.538, 1.581)   
  Met strength rec. only 1.238 (0.618, 2.479)   
  Did not meet either rec. 0.939 (0.558, 1.580)   
Sleep Duration 0.000 
  1-4 hours of sleep 2.412 (1.139, 5.107) * 
  5-6 hours of sleep 1.206 (0.784, 1.855)   
  7-9 hours of sleep (ref.)       
  10-18 hours of sleep 7.170 (3.284, 15.654) * 
Smoking 0.239 
  Never smoked (ref.)       
  Former smoker 1.443 (0.943, 2.208)   
  Current smoker 1.180 (0.693, 2.007)   
Heavy Drinking       0.030 
  No heavy drinking (ref.)       
  Yes heavy drinking 0.459 (0.227, 0.929) * 
Dark Green Vegetable intake per day 0.226 
  Continuous variable        
Cardiovascular conditions include myocardial infarction, coronary heart disease or angina, and 
stroke. * indicates p value < .05 
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Discussion 
 The primary goals of this study were to determine: 1) if deficient sleep is 
associated with a cardiovascular condition, 2) if excessive sleep duration is associated 
with a cardiovascular condition, and 3) which demographic, co-morbid, and/or behavioral 
factors are associated with a cardiovascular condition. The null hypotheses for all three 
research questions were rejected when analyzed with multiple logistic regression. 
Demographic variables age and gender were significantly associated with cardiovascular 
disease, but gender became insignificant after all eleven variables were entered into the 
final model. All co-morbid variables were significant in the initial analysis i.e. high blood 
pressure, high cholesterol, diabetes, BMI, and depression. After addition to the final 
model, only high blood pressure, high cholesterol, and depressive disorder remained 
significant. Sleep duration, smoking and alcohol consumption were significant in the 
initial analysis; physical activity, and dark green vegetable daily intake approached 
significance. Once all the behavioral models were added to the final model, only sleep 
duration and alcohol consumption remained statistically significant.  
 Sleep duration, the intended variable of interest, remained significant in both the 
behavioral block analysis and the final block analysis. Both subgroups 1-4 hours and 10-
18 hours of sleep remained statistically significant with both odds ratios increasing and a 
steady p value. In contrast, sleep subgroup ‘5-6 hours’ never reached significance in 
either analysis and both confidence intervals crossed 1 in the analyses. This may be due 
to different sample sizes among each subgroup. Both extreme subgroups e.g. 1-4 hours, 
and 10-18 hours, had sample sizes of less than 4% each, compared to 5-6 hours with a 
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weighted sample size of 31.5%. However, many studies still showed the extreme 
subgroups of deficient and excessive sleep are significant, and associated with 
cardiovascular disease and its various conditions. Altman et al. (2012) found those with 
the highest risk for heart attack and stroke were among individuals who slept less than 5 
hours or more than 9 hours.  Additionally, Kronholm et al. (2011) found the highest risk 
of CVD mortality was among those on the extreme ends of sleep duration distribution. In 
conjunction, Suzuki et al.’s similar study identified an association with excessive sleep 
duration and a higher risk of cardiovascular mortality (2009). These studies are consistent 
with this study and have observed similar findings, therefore, giving validity to the results 
found despite the smaller weighted percentage for the extreme sleep subgroups. 
 Epidemiologic studies also support the associations found in the results between 
age, high blood pressure, high cholesterol, and depression, with sleep duration, and 
cardiovascular disease conditions. Huang et al. (2013) found a greatly increased risk for 
stroke in the elderly with a non-apnea sleep disorder, as well as the study by 
Sabanayagam & Shankar (2010) whom had positive associations with CVD, age 
subgroups, and sleep duration. Both short and long sleep, similar to this study, were 
positively associated with cardiovascular disease, and other health risks like high blood 
pressure, obesity, and diabetes (Buxton & Marcelli, 2010). Although obesity and diabetes 
did not remain significant in the final model, this may be due to the interactive effects 
between confounders. Regardless, a review paper from Grander et al. (2013) confirmed 
that “there is strong evidence for sleep duration, both short and long, as a risk factor for 
CVD, even though the mechanisms are not understood”. Grander et al. (2013) also 
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suggests that high cholesterol causes inflammation and is a potential pro-inflammatory 
biomarker for the development of CVD. Similarly to this study, the significant variable 
‘depression’, has also been found to be associated or related with both sleep 
insufficiency, and cardiovascular risk (MMWR, 2011; Sabanayagam & Shankar, 2010).  
 Lastly, heavy drinking was shown to be protective against myocardial infarction, 
coronary heart disease or angina, and stroke. Probable explanations for this protective 
association may be due to the wording of the question in the BRFSS. The survey question 
for heavy drinking classifies men consuming ‘two or more drinks per day’ or women 
consuming ‘one or more drinks per day’ as heavy drinkers. One or two drinks per day on 
average may be considered light to moderate alcohol consumption, not heavy or binge 
drinking (Berger et al., 1999). Another explanation may perhaps be alcohol has been 
found to be protective against various brain diseases such as mild cognitive impairment, 
and vascular dementia (Panza et al., 2012). Moreover, light to moderate alcohol 
consumption has also been found to reduce the overall risk of stroke, and the risk of 
ischemic stroke in men according to a study published in the New England Journal of 
Medicine (Berger et al., 1999).  Generally known as a vasodilator, alcohol relaxes the 
smooth muscles in the arteries allowing for widening and improved blood flow. This may 
be indicative as to why the findings from this study show one or more drinks per night 
may be protective against cardiovascular conditions. Based on these explanations, the 
results of this study shows consistency with others mentioned and makes a compelling 
case for an association between sleep duration, various variables, and cardiovascular 
conditions.  
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Strengths and Limitations 
 The major strengths of this study include the large data set with over 5,000 
participants and its population-based study design. Population-based studies allow for a 
more honest representation of the state and are deemed valid. This study is generalizable 
due to the BRFSS weighting and inclusion of individuals who rely on cellular phones, not 
landlines. This may also eliminate selection biases based on characteristics of persons 
who don’t own a cell phone versus those who do. In addition, the BRFSS accurately 
measures prevalence based on matching other prevalent rates from other national studies. 
Its large data set also allows for the study of multiple outcomes and exposures. Although 
the sample sizes for the cardiovascular conditions are small, the combining of the three 
variables e.g. myocardial infarction, coronary heart disease or angina, and stroke, allows 
for a more robust sample, and thus, increases the power of the study. Lastly, the 
Nagelkerke’s R-square value calculated for the final model accounted for 26.4% of the 
variability for a cardiovascular condition. This strengthens the findings of the study 
because the variables in the final model were able to explain over a quarter of the 
variability for the cardiovascular condition, thus giving additional explanatory power to 
the multiple logistic regression model.   
 Limitations of this study may include the cross sectional nature of the BRFSS as 
well as its self-reported measures. Self-reported measures can be susceptible to 
misclassification due to recall bias. Recall bias is characteristic of participants recalling 
past exposures based on memory alone and can be a threat to the internal validity of a 
study.   The BRFSS survey also only includes non-institutionalized and non-incarcerated 
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persons. Individuals in nursing or caregiver homes are unable to complete this survey and 
may cause an underestimation of the dependent variable. In addition to this selection bias, 
the BRFSS survey does not permit proxy interviews. For this study, a proxy interview 
may be needed for individuals who had suffered a stroke. Stroke victims commonly have 
paralysis of the facial muscles and have difficulty with speech and hearing. The stroke 
sample for this study is small with only three percent reporting the condition, yet when 
compared to the national average, Nevada has a higher prevalence of stroke. Thus, stroke 
victims may be underrepresented in the dependent variable and sample.  
 Continuing, causal inferences cannot be made from this study because of its cross 
sectional design. A cross sectional study design cannot accurately determine whether the 
outcome followed the exposure in time or the exposure resulted from the outcome. 
Essentially, this study is unable to say if deficient or excessive sleep caused 
cardiovascular conditions or vice versa. It can only be said that a negative association 
exists between the variables and any assumptions made should be cautious. Furthermore, 
the hypotheses created for this study may be susceptible to Neyman bias, commonly 
known as selective survival bias. Selective survival bias is when an outcome such a 
myocardial infarction or stroke may result in death, and thus, the individual whom could 
have participated in the study was unable because they died of the condition. This could 
affect the study by underestimating the findings since the dependent variable isn’t a true 
reflection of those with the disease or condition. Additionally, those who may have died 
from the disease or condition may be different than the population of the study. These 
deceased individuals could have more co-morbidities and may have different sleep 
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patterns than those who survived the condition or disease. This selective survival bias has 
the potential to underestimate the associations between the dependent and independent 
variables.  
Public Health and Clinical Application 
 To reduce cardiovascular conditions, public health officials may benefit from 
targeting sleep duration by developing sleep recommendations and treatment strategies. 
The National Sleep Foundation has recommended for those to practice sleep hygiene, a 
technique to help promote the quality and duration of sleep. Some sleep hygiene tips 
include not napping during the day, avoiding stimulants such as caffeine and nicotine 
many hours before bed, avoiding alcohol before bed, not consuming large meals before 
bed, and practicing relaxing exercises such as yoga. For individuals diagnosed with 
apnea-related sleep disorders, continuous positive airway pressure (CPAP) has been 
shown to be an effective treatment. For individuals with non-apnea sleep disorders, over 
the counter medications such as acetaminophen PM pills and night syrups can be used 
and is non-habit forming. Prescribed medications from a physician can also be used to 
treat chronic sleep problems. Natural remedies, a common suggestion by doctors of 
osteopathic medicine, suggest supplements such as melatonin and/or chamomile or mint 
tea. Cognitive behavioral therapy has also been proposed as an effective treatment 
(National Sleep Foundation, 2014).  
 Treatment of the modifiable risk factors identified in this study is important as 
well to reduce cardiovascular conditions. Blood pressure and cholesterol should be 
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monitored by health care professionals and treated by prescribing medications along with 
encouraging healthy diet and activity modifications. Monitoring and treating both high 
blood pressure and high cholesterol is easily done by primary care physicians, physician 
assistants, and registered nurses. Less healthcare resources are utilized by treating these 
risk factors with behavioral modifications as well as medications such as diuretics, beta-
blockers, ACE inhibitors and statins. Treating a cardiovascular condition in a hospital 
setting including ambulatory services, emergency department usage, and urgent care is 
extremely costly and critical interventions could help reduce the financial and global 
impact of this condition. Antidepressants are also more easily treatable through 
medications such as SSRIs or SNRIs, therapy, and social support. Overall, there is less 
economic burden to the system when preventive strategies handled through the primary 
care setting is utilized compared to hospital emergency care settings.  
 Federal funding will be needed to help develop, and promote sleep 
recommendations, and treatment strategies like the techniques recommended by the 
National Sleep Foundation. Public health policy is based on current literature and 
therefore, more definitive studies are needed to identify the true relationship between 
sleep and the development of cardiovascular diseases and its various conditions. It is 
highly recommended that a prospective cohort be funded and endorsed; only then can a 
true relationship between deficient or excessive sleep and cardiovascular disease 
development be found. The future study will determine whether the outcome 
(cardiovascular condition) precedes the exposure (sleep duration), or the exposure 
precedes out the outcome.  Prospective cohorts, similar to the Framingham Heart study, 
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are capable of making important scientific contributions and identify common risk factors 
or characteristics that contribute to diseases. Moreover, determining these risk factors or 
characteristics inevitably leads to the development of new and effective treatments and 
preventive strategies in both public health policy and clinical practice.  
Conclusion 
 In conclusion, this study shows that both deficient, and excessive sleep duration, 
are associated with cardiovascular conditions i.e. myocardial infarction, coronary heart 
disease or angina, and stroke. Future prospective cohort studies are needed to determine 
the true relationship between sleep and cardiovascular conditions. Primary prevention 
and guidelines for the treatment of high blood pressure, high cholesterol, and depression, 
will also be necessary to reduce risk. If future studies support the results in this study, 
sleep recommendations and treatment strategies can be constructed. Although sleep 
recommendations by organizations such as The National Sleep Foundation exist, further 
research and funding on improving and treating ineffectual sleep will be needed to lower 
the risk and economic burden of cardiovascular disease, and its conditions.  
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Appendix A 
Relevant Health Condition Questions from BRFSS 
Section 4: Inadequate Sleep 
 
I would like to ask you about your sleep pattern.  
 
4.1   On average, how many hours of sleep do you get in a 24-hour period?  
 
INTERVIEWER NOTE: Enter hours of sleep in whole numbers, rounding 30 minutes (1/2 hour) or 
more up to the next whole hour and dropping 29 or fewer minutes.  
(91-92)  
_ _  Number of hours [01-24]  
7 7  Don’t know / Not sure  
                   9 9  Refused 
Section 5:  Hypertension Awareness 
 
5.1 Have you EVER been told by a doctor, nurse, or other health professional that you have  
  high blood pressure?         
(93) 
Read only if necessary:  By “other health professional” we mean a nurse practitioner, a physician’s 
assistant, or some other licensed health professional.  
If “Yes” and respondent is female, ask: “Was this only when you were pregnant?” 
 
  1 Yes 
  2 Yes, but female told only during pregnancy  [Go to next section] 
   3 No      [Go to next section] 
    4 Told borderline high or pre-hypertensive  [Go to next section] 
  7 Don’t know / Not sure    [Go to next section] 
  9 Refused     [Go to next section] 
Section 6: Cholesterol Awareness 
 
6.3 Have you EVER been told by a doctor, nurse or other health professional that your blood 
 cholesterol is high?  
(97) 
 1 Yes          
  2 No 
 7 Don’t know / Not sure 
 9 Refused 
Section 7:  Chronic Health Conditions  
  Now I would like to ask you some questions about general health conditions. Has a doctor, nurse, or other 
health professional EVER told you that you had any of the following? For each, tell me “Yes,” “No,” or 
you’re “Not sure.” 
7.1  (Ever told) you that you had a heart attack also called a myocardial infarction? 
(98) 
1 Yes 
2 No  
7 Don’t know / Not sure  
9 Refused   
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7.2 (Ever told) you had angina or coronary heart disease? 
(99) 
1 Yes 
2 No  
7 Don’t know / Not sure  
9 Refused   
 
7.3 (Ever told) you had a stroke? 
  (100) 
1 Yes 
2 No  
7 Don’t know / Not sure  
9 Refused   
 
7.10 (Ever told) you have a depressive disorder, including depression, major depression, 
dysthymia, or minor depression? 
(107) 
1 Yes 
2 No  
7 Don’t know / Not sure  
9 Refused   
7.12 (Ever told) you have diabetes?       
                             (109) 
If “Yes” and respondent is female, ask: “Was this only when you were pregnant?” 
 If respondent says pre-diabetes or borderline diabetes, use response code 4. 
 
 1 Yes 
  2 Yes, but female told only during pregnancy 
  3 No 
  4 No, pre-diabetes or borderline diabetes 
  7 Don’t know / Not sure 
  9 Refused 
 
CATI note: If Q7.12 = 1 (Yes), go to Diabetes Optional Module (if used). If any other response to 
Q7.12, go to Pre-Diabetes Optional Module (if used), otherwise, go to next section. 
Section 9: Tobacco Use             
   
9.2 Do you now smoke cigarettes every day, some days, or not at all? 
          
 (188) 
 1 Every day 
 2 Some days 
 3 Not at all   [Go to Q9.4]  
 7 Don’t know / Not sure [Go to Q9.5] 
 9 Refused   [Go to Q9.5]  
 
9.4 How long has it been since you last smoked a cigarette, even one or two puffs?  
(190-191) 
 0 1 Within the past month (less than 1 month ago) 
 0 2 Within the past 3 months (1 month but less than 3 months ago) 
 0 3 Within the past 6 months (3 months but less than 6 months ago) 
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 0 4 Within the past year (6 months but less than 1 year ago) 
 0 5 Within the past 5 years (1 year but less than 5 years ago) 
 0 6 Within the past 10 years (5 years but less than 10 years ago) 
 0 7 10 years or more  
 0 8 Never smoked regularly 
 7 7 Don’t know / Not sure 
 9 9 Refused 
Section 10: Alcohol Consumption  
 
10.1   During the past 30 days, how many days per week or per month did you have at 
least one drink of any alcoholic beverage such as beer, wine, a malt beverage or liquor? 
          
(193-195) 
1 _ _  Days per week 
2 _ _  Days in past 30 days 
8 8 8  No drinks in past 30 days  [Go to next section] 
7 7 7  Don’t know / Not sure  [Go to next section] 
9 9 9  Refused   [Go to next section] 
 
10.2   One drink is equivalent to a 12-ounce beer, a 5-ounce glass of wine, or a drink 
with one shot of liquor. During the past 30 days, on the days when you drank, about how 
many drinks did you drink on the average?      
        (196-197) 
 
NOTE: A 40 ounce beer would count as 3 drinks, or a cocktail drink with 2 shots 
would count as 2 drinks. 
 
_ _  Number of drinks 
7 7  Don’t know / Not sure 
9 9  Refused 
 
10.3  Considering all types of alcoholic beverages, how many times during the past 30 days 
did you have X [CATI X = 5 for men, X = 4 for women] or more drinks on an 
occasion? 
    (198-199) 
_ _  Number of times 
8 8  None 
7 7  Don’t know / Not sure 
9 9  Refused 
Section 11: Fruits and Vegetables  
  
These next questions are about the fruits and vegetables you ate or drank during the past 30 days. Please 
think about all forms of fruits and vegetables including cooked or raw, fresh, frozen or canned. Please think 
about all meals, snacks, and food consumed at home and away from home. 
 
I will be asking how often you ate or drank each one: for example, once a day, twice a week, three times a 
month, and so forth. 
11.4 During the past month, how many times per day, week, or month did you eat dark green 
vegetables for example broccoli or dark leafy greens including romaine, chard, collard 
greens or spinach?  
(211-213) 
 1 _ _ Per day 
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 2 _ _ Per week 
 3 _ _     Per month 
  5 5 5  Never 
 7 7 7  Don’t know / Not sure 
 9 9 9  Refused 
 
INTERVIEWER NOTE: Each time a vegetable is eaten it counts as one time.  
INTERVIEWER NOTE: Include all raw leafy green salads including spinach, mesclun, romaine 
lettuce, bok choy, dark green leafy lettuce, dandelions, komatsuna, watercress, and arugula. 
 
Do not include iceberg (head) lettuce if specifically told type of lettuce. Include all cooked greens 
including kale, collard greens, choys, turnip greens, mustard greens.  
Section 12: Exercise (Physical Activity)  
  
The next few questions are about exercise, recreation, or physical activities other than your regular job 
duties. 
 
INTERVIEWER INSTRUCTION: If respondent does not have a “regular job duty” or is retired, 
they may count the physical activity or exercise they spend the most time doing in a regular month. 
 
12.2.   What type of physical activity or exercise did you spend the most time doing 
during the past month?                   
        (221-222) 
  _ _        (Specify)   [See Physical Activity Coding List]             
  7 7  Don’t know / Not Sure [Go to Q12.8] 
9 9 Refused   [Go to Q12.8] 
 
INTERVIEWER INSTRUCTION: If the respondent’s activity is not included in the Physical 
Activity Coding List, choose the option listed as “Other “. 
 
12.3 How many times per week or per month did you take part in this activity during the past 
month?  
(223-225) 
 1_ _ Times per week 
 2_ _ Times per month 
  7 7 7 Don’t know / Not sure   
 9 9 9 Refused  
 
12.4 And when you took part in this activity, for how many minutes or hours did you usually 
keep at it? 
(226-228) 
  _:_ _  Hours and minutes  
 7 7 7      Don’t know / Not sure 
 9 9 9 Refused   
 
12.5   What other type of physical activity gave you the next most exercise during the past 
month?               
          (229-230) 
  _ _        (Specify)   [See Physical Activity Coding List]  
 8 8 No other activity  [Go to Q12.8] 
 7 7 Don’t know / Not Sure [Go to Q12.8] 
  9 9 Refused   [Go to Q12.8] 
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INTERVIEWER INSTRUCTION: If the respondent’s activity is not included in the Coding Physical 
Activity List, choose the option listed as “Other”. 
 
12.6 How many times per week or per month did you take part in this activity during the past 
month?  
(231-233) 
 1_ _ Times per week 
 2_ _ Times per month 
  7 7 7 Don’t know / Not sure   
 9 9 9 Refused  
 
12.7 And when you took part in this activity, for how many minutes or hours did you usually 
keep at it? 
(234-236) 
  _:_ _  Hours and minutes  
 7 7 7      Don’t know / Not sure 
 9 9 9 Refused   
 
12.8 During the past month, how many times per week or per month did you do physical  
 activities or exercises to STRENGTHEN your muscles? Do NOT count aerobic activities 
like walking, running, or bicycling. Count activities using your own body weight like 
yoga, sit-ups or push-ups and those using weight machines, free weights, or elastic bands. 
(237-239) 
 1_ _ Times per week 
 2_ _ Times per month 
  8 8 8 Never 
  7 7 7 Don’t know / Not sure   
 9 9 9 Refused  
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Appendix B 
List of Acronyms 
BRFSS  Behavioral Risk Factor Surveillance System 
CDC  Centers for Disease Control 
CHD  Coronary Heart Disease 
CI  Confidence Interval  
CVD  Cardiovascular Disease 
DV  Dependent Variable 
IV   Independent Variable  
MI  Myocardial Infarction 
OR  Odds Ratio  
SPSS  Statistical Package for the Social Sciences 
UNLV  University of Nevada, Las Vegas 
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Appendix C 
BRFSS Description of Weights Table 
The final BRFSS data set includes several variables that are used in the weighting 
process. The following table explains data weighting variables:  
 
 
Weighting Variables Included in the BRFSS Dataset  
Variable 
Name  Description  
_LLCP_WGT 
The final weight assigned to each respondent for the landline 
telephone and cellular telephone combined data. This weight should be 
used when landline telephone and cellular telephone data are included 
in analyses. 
_LANDWT 
The weight assigned to each respondent for the landline telephone 
sample only. This weight should be used in analyses of landline 
telephone data when cellular telephone data are not included. 
_STRWT 
Stratum weight accounts for differences in the basic probability of 
selection among strata (subsets of area code/prefix combinations). It is 
the inverse of the sampling fraction of each stratum. There almost 
never is a complete correspondence between strata, which are defined 
by subsets of area code/prefix combinations, and regions, which are 
defined by the boundaries of government entities. 
NUMPHON2 
The number of residential telephone numbers in the respondent's 
house.  
NUMADULT The number of adults in the respondent household. 
NRECSEL Number of records selected to be included in the sample.  
NRECSTR Number of records available in the strata.  
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Appendix D 
Regression Statistic Tables 
Table 1: Regression Statistics for Demographic Factors (Block 1) 
Cox and Snell 0.071 
Nagelkerke  0.163 
McFadden 0.128 
 
Table 2: Regression Statistics for Co-Morbid Factors (Block 2) 
Cox and Snell 0.083 
Nagelkerke  0.173 
McFadden 0.133 
 
Table 3: Regression Statistics for Behavioral Factors (Block 3) 
Cox and Snell 0.040 
Nagelkerke  0.090 
McFadden 0.690 
 
Table 4: Regression Statistics for Final Model (Block 4) 
Cox and Snell 0.126 
Nagelkerke  0.264 
McFadden 0.207 
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